Company: HYEX
Filing Date: 2025-10-02
Form Type: 8-K
Source: 0001096906-25-001627
Chunk: 5

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-10-02
Form: 8-K
Item: Item 5.02
Chunk 5
---
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

See the description of the Acquisition of Gummy USA LLC in Item 1.01 and 1.02.

In connection with, and as a material term of, the transaction, effective on September 30, 2025, Donald Swanson was re-appointed to our Board of Directors as our fourth director, Chairman, and as our Chief Executive Officer. Kevin “ Duke” Pitts, who was our President prior to the transaction, was re-appointed as our President and Chief Operating Officer.

Donald Swanson, age 67, was appointed as a member of our Board of Directors, Chairman, and as our Chief Executive Officer on September 30, 2025. Mr. Swanson was the founder and has been the CEO of Gummy USA LLC since its inception in 2021. Mr. Swanson brings over eight years of deep experience in pharmaceutical-grade manufacturing and gummy innovation. He has successfully designed and implemented state-of-the-art production facilities across multiple international locations, and his proprietary processes deliver unmatched precision. Under his leadership, Gummy USA has not only secured significant purchase orders but also positioned itself to set a new industry benchmark for quality, regulatory compliance, and supply chain efficiency. His expertise spans automated controls, advanced fluid dynamics, and blockchain-enabled product authentication, solving critical production inefficiencies and protecting brand integrity.

There are no family relationships between any of our officers or directors. Other than the transactions in connection with the acquisition of Gummy USA LLC, there are no transactions with related persons.

On October 1, 2025, William Bossung resigned as a member of our Board of Directors.

3

Section 9 - Financial Statements and Exhibits.

Item 9.01Financial Statements and Exhibits.